Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fibroblast heterogeneity in scleroderma: Clq studies.

D B Maxwell1, C A Grotendorst, G R Grotendorst

  • 1Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston 29425.

The Journal of Rheumatology
|August 1, 1987
PubMed
Summary

Fibroblast heterogeneity in scleroderma may involve the overgrowth of specific collagen-producing cells. Higher Clq binding in early scleroderma fibroblasts supports a clonal selection theory for this autoimmune disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between polymorphic variation in VDR and RXRA and circulating levels of vitamin D metabolites.

The Journal of steroid biochemistry and molecular biology·2010
Same author

The 72-kilodalton IE-1 protein of human cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts.

Clinical and experimental rheumatology·2004
Same author

A profibrotic polymorphism (of TGFbeta1) in systemic sclerosis.

Annals of the rheumatic diseases·2002
Same author

Connective tissue growth factor is directly related to liver fibrosis.

Hepato-gastroenterology·2002
Same author

Anti-fibrillin-1 autoantibodies in systemic sclerosis are GM and KM allotype-restricted.

Experimental and clinical immunogenetics·2001
Same author

MCMV induces neointima in IFN-gammaR-/- mice: intimal cell apoptosis and persistent proliferation of myofibroblasts.

BMC musculoskeletal disorders·2001

Area of Science:

  • Connective tissue diseases
  • Cellular immunology
  • Dermatology

Background:

  • Fibroblast heterogeneity is a proposed mechanism in scleroderma pathogenesis.
  • A subpopulation of high collagen-producing fibroblasts may expand selectively.
  • Fibroblast membrane Clq receptor affinity correlates with collagen production in other cell types.

Purpose of the Study:

  • To investigate the role of fibroblast heterogeneity in scleroderma.
  • To examine Clq binding in fibroblasts from scleroderma patients.
  • To assess the validity of the clonal selection theory in scleroderma.

Main Methods:

  • Fibroblast cultures from patients with early and late scleroderma, and controls.
  • Quantification of Clq binding to fibroblast cell membranes.

Related Experiment Videos

  • Comparison of Clq binding levels across patient groups.

    • Main Results:

    • Fibroblasts from early scleroderma patients showed significantly higher Clq binding than those from late scleroderma patients and controls.
    • These findings suggest an increased presence or activity of a specific fibroblast subpopulation in early disease.

    Conclusions:

    • The results support the theory that scleroderma pathogenesis involves the selective overgrowth of a specific fibroblast subpopulation.
    • Clonal selection may play a significant role in the development and progression of scleroderma.
    • Fibroblast Clq binding serves as a potential marker for this cellular expansion.